Xianglin L. Du - Publications

Affiliations: 
Epidemiology & Disease Control The University of Texas School of Public Health 
Area:
Epidemiology

180 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Du XL, Li Z. Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race/ethnicity, age and tumor stage. American Journal of Cancer Research. 13: 678-691. PMID 36895969  0.308
2022 Fwelo P, Yusuf ZI, Adjei A, Huynh G, Du XL. Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017. Breast Cancer Research and Treatment. 194: 643-661. PMID 35749020 DOI: 10.1007/s10549-022-06653-w  0.318
2022 Du X. Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States. Molecular and Clinical Oncology. 16: 95. PMID 35368847 DOI: 10.3892/mco.2022.2528  0.342
2022 Du XL, Song L. Age and Racial Disparities in the Utilization of Anticancer, Antihypertension, and Anti-diabetes Therapies, and in Mortality in a Large Population-Based Cohort of Older Women with Breast Cancer. Journal of Racial and Ethnic Health Disparities. PMID 35040106 DOI: 10.1007/s40615-022-01235-4  0.309
2021 Du XL, Song L. Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage. Cancer Epidemiology. 76: 102076. PMID 34861613 DOI: 10.1016/j.canep.2021.102076  0.326
2019 Farias AJ, Ochoa CY, Toledo G, Bang SI, Hamilton AS, Du XL. Racial/ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis: findings from the SEER-CAHPS data. Cancer Causes & Control : Ccc. PMID 31797123 DOI: 10.1007/S10552-019-01254-3  0.439
2019 Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Zhao B, Du XL. Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia. PMID 31563564 DOI: 10.1016/J.Clml.2019.08.014  0.342
2019 Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head & Neck. PMID 31441572 DOI: 10.1002/Hed.25923  0.319
2019 Mungi C, Lai D, Du XL. Spatial Analysis of Industrial Benzene Emissions and Cancer Incidence Rates in Texas. International Journal of Environmental Research and Public Health. 16. PMID 31344779 DOI: 10.3390/Ijerph16152627  0.314
2019 Zhu P, Du XL, Zhu JJ, Esquenazi Y. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. Journal of Neurosurgery. 1-12. PMID 30771780 DOI: 10.3171/2018.10.Jns182247  0.416
2019 Davis CH, Gaglani T, Moore LW, Du XL, Hwang H, Yamal JM, Bailey HR, Cusick MV. Trends and Outcomes in Laparoscopic versus Open Surgery for Rectal Cancer from 2005 to 2016 Using the ACS-NSQIP Database, a Retrospective Cohort Study. International Journal of Surgery (London, England). PMID 30771485 DOI: 10.1016/J.Ijsu.2019.02.006  0.371
2019 Nguyen C, Lairson DR, Swartz MD, Du XL. Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective. Journal of Managed Care & Specialty Pharmacy. 25: 225-234. PMID 30698095 DOI: 10.18553/Jmcp.2019.25.2.225  0.312
2019 Zhu P, Du XL, Esquenazi Y, Zhu J. Access to clinical trials, multidisciplinary environment, and health care providers by facility type and outcomes of patients with newly diagnosed glioblastoma using SEER-Medicare dataset. Journal of Clinical Oncology. 37: e13576-e13576. DOI: 10.1200/Jco.2019.37.15_Suppl.E13576  0.386
2019 Kabadi SM, Goyal RK, Nagar SP, Davis KL, Le H, Du XL, Jain P, Wang ML, Romaguera JE, Kaye JA. Overall Survival, Adverse Events, and Economic Burden in Medicare-Insured Patients with Mantle Cell Lymphoma Receiving Cancer-Directed Therapy Blood. 134: 63-63. DOI: 10.1182/Blood-2019-122841  0.464
2019 Zhu P, Du X, Zhu J. EPID-16. COMPARATIVE ANALYSIS OF OVERALL SURVIVAL AND ADVERSE EVENTS BY ADJUVANT TREATMENT MODALITIES IN ELDERLY PATIENTS WITH GLIOBLASTOMA USING THE SEER-MEDICARE DATABASE Neuro-Oncology. 21: vi77-vi78. DOI: 10.1093/Neuonc/Noz175.316  0.395
2018 Fu S, Wang M, Li R, Lairson DR, Zhao B, Du XL. Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas. Cancer Epidemiology. 58: 89-97. PMID 30528835 DOI: 10.1016/J.Canep.2018.12.002  0.384
2018 Farias AJ, Wu WH, Du XL. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data. Bmc Cancer. 18: 1214. PMID 30514270 DOI: 10.1186/S12885-018-5121-Z  0.431
2018 Chen TH, Du XL, Chan W, Zhang K. Impacts of cold weather on emergency hospital admission in Texas, 2004-2013. Environmental Research. 169: 139-146. PMID 30453131 DOI: 10.1016/J.Envres.2018.10.031  0.334
2018 Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. Jama Otolaryngology-- Head & Neck Surgery. PMID 30193299 DOI: 10.1001/Jamaoto.2018.1791  0.338
2018 Nguyen C, Lairson DR, Swartz MD, Du XL. Risks of Major Long-term Side Effects Associated with Androgen Deprivation Therapy in Men with Prostate Cancer. Pharmacotherapy. PMID 30080934 DOI: 10.1002/Phar.2168  0.336
2018 Nguyen C, Lairson DR, Swartz MD, Du XL. Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer. Journal of Racial and Ethnic Health Disparities. PMID 29959759 DOI: 10.1007/S40615-018-0508-8  0.344
2018 Farias AJ, Wu WH, Du XL. Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer. Medical Oncology (Northwood, London, England). 35: 113. PMID 29926275 DOI: 10.1007/S12032-018-1168-6  0.502
2018 Kim J, Rajan SS, Du XL, Franzini L, Giordano SH, Morgan RO. Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas. Breast Cancer Research and Treatment. PMID 29423900 DOI: 10.1007/S10549-018-4704-3  0.379
2018 Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. PMID 29393964 DOI: 10.1002/Cncr.31155  0.427
2018 Chen Y, Lairson DR, Chan W, Du XL. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma. Annals of Hematology. PMID 29333596 DOI: 10.1007/S00277-018-3238-4  0.382
2018 Tam S, Du XL, Lewis CM, Yamal J, Weber RS. The effect of facility volume on treatment guideline compliance and overall survival in oral tongue squamous cell carcinoma. Journal of Clinical Oncology. 36: 17-17. DOI: 10.1200/Jco.2018.36.30_Suppl.17  0.428
2018 Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Du XL. Effects of bendamustine, bortezomib, and rituximab on 1-year survival rates in elderly patients newly diagnosed with mantle cell lymphoma. Journal of Clinical Oncology. 36: e19537-e19537. DOI: 10.1200/Jco.2018.36.15_Suppl.E19537  0.363
2018 Zhu P, Du X, Esquenazi Y, Zhu J. EPID-01. ASSOCIATIONS OF TIMING OF ADJUVANT THERAPIES, RADIATION FRACTIONS AND RADIATION DOSES WITH GLIOBLASTOMA SURVIVAL: A RETROSPECTIVE COHORT ANALYSIS USING THE NATIONAL CANCER DATABASE AND SEER-MEDICARE DATABASE Neuro-Oncology. 20: vi80-vi80. DOI: 10.1093/Neuonc/Noy148.328  0.359
2018 Zhu P, Du XL, Esquenazi Y, Zhu J. 51 Timing of adjuvant treatments on glioblastoma survival: A retrospective cohort analysis based on the national cancer database Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 45: S11-S12. DOI: 10.1017/Cjn.2018.291  0.415
2018 Fu S, Wang M, Zhao H, Li R, Lairson D, Giordano S, Zhao B, Du X. Effects of Rituximab, Bortezomib, and Bendamustine on the Survival in Medicare Beneficiaries with Mantle Cell Lymphoma Clinical Lymphoma Myeloma and Leukemia. 18: S273-S274. DOI: 10.1016/J.Clml.2018.07.198  0.336
2017 Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas. Oncotarget. 8: 112516-112529. PMID 29348844 DOI: 10.18632/Oncotarget.22367  0.358
2017 Wu Y, Liu H, Du XL, Wang F, Zhang J, Cui X, Li E, Yang J, Yi M, Zhang Y. Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II-IV rectal cancer. Oncotarget. 8: 106913-106925. PMID 29290999 DOI: 10.18632/Oncotarget.22460  0.449
2017 Yang J, Du XL, Li S, Wu Y, Lv M, Dong D, Zhang L, Chen Z, Wang B, Wang F, Shen Y, Li E, Yi M, Yang J. The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012. Bmc Cancer. 17: 783. PMID 29166866 DOI: 10.1186/S12885-017-3765-8  0.398
2017 Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer. PMID 29140558 DOI: 10.1002/Cncr.31094  0.434
2017 Chen Y, Lairson DR, Chan W, Du XL. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort. Medical Oncology (Northwood, London, England). 34: 153. PMID 28776319 DOI: 10.1007/S12032-017-1001-7  0.432
2017 Farias AJ, Du XL. Racial differences in adjuvant endocrine therapy use and discontinuation in association with mortality among Medicare breast cancer patients by receptor status. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28515111 DOI: 10.1158/1055-9965.Epi-17-0280  0.412
2017 Zhu P, Du XL, Lu G, Zhu JJ. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study. Oncotarget. PMID 28467795 DOI: 10.18632/Oncotarget.17054  0.423
2017 Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu P, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget. PMID 28410201 DOI: 10.18632/Oncotarget.16694  0.405
2017 Farias AJ, Du XL. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 86-95. PMID 28034069 DOI: 10.1200/Jco.2016.68.2807  0.428
2017 Parikh RC, Du XL, Robert MO, Lairson DR. Cost-Effectiveness of Treatment Sequences of Chemotherapies and Targeted Biologics for Elderly Metastatic Colorectal Cancer Patients. Journal of Managed Care & Specialty Pharmacy. 23: 64-73. PMID 28025930 DOI: 10.18553/Jmcp.2017.23.1.64  0.4
2017 Zhu P, Du X, Zhu J, Esquenazi Y. HOUT-12. IMPROVED SURVIVAL OF GLIOBLASTOMA PATIENTS TREATED AT ACADEMIC CANCER PROGRAMS: A HOSPITAL-BASED STUDY FROM THE NATIONAL CANCER DATABASE Neuro-Oncology. 19: vi108-vi108. DOI: 10.1093/Neuonc/Nox168.443  0.436
2017 Zhu P, Du X, Lu G, Zhu J. EPID-02. SURVIVAL BENEFIT OF GLIOBLASTOMA PATIENTS AFTER FDA APPROVAL OF BEVACIZUMAB, A POPULATION-BASED STUDY USING SEER, TCR, AND NCDB DATABASES Neuro-Oncology. 19: vi69-vi69. DOI: 10.1093/Neuonc/Nox168.280  0.376
2016 Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D, Wang F, Li EX, Yi M, Yang J. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. Plos One. 11: e0167540. PMID 27936129 DOI: 10.1371/Journal.Pone.0167540  0.409
2016 Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients. Drugs - Real World Outcomes. 3: 69-82. PMID 27747803 DOI: 10.1007/S40801-015-0059-9  0.438
2016 Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Use of Hematopoietic Growth Factors and Risk of Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. PMID 27365286 DOI: 10.1016/J.Whi.2016.05.007  0.404
2016 Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. Plos One. 11: e0156617. PMID 27244238 DOI: 10.1371/Journal.Pone.0156617  0.448
2016 Liu Z, Zhang K, Du XL. Risks of developing breast and colorectal cancer in association with incomes and geographic locations in Texas: a retrospective cohort study. Bmc Cancer. 16: 294. PMID 27118258 DOI: 10.1186/S12885-016-2324-Z  0.438
2016 Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients. Drugs - Real World Outcomes. 3: 69-82. PMID 27073759 DOI: 10.1007/s40801-015-0059-9  0.329
2016 Du XL, Zhang Y, Hardy D. Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer. Cancer Causes & Control : Ccc. PMID 27059219 DOI: 10.1007/S10552-016-0742-5  0.368
2016 Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D. Medical Oncology (Northwood, London, England). 33: 19. PMID 26786154 DOI: 10.1007/S12032-016-0732-1  0.46
2016 Farias A, Du XL. Racial/ethnic difference in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer. Journal of Clinical Oncology. 34: e18076-e18076. DOI: 10.1200/Jco.2016.34.15_Suppl.E18076  0.433
2016 Parikh R, Du X, Morgan R, Lairson D. Cost Effectiveness of Treatment Sequences for Elderly Metastatic Colorectal Cancer Patients: A Seer-Medicare-Based Modelling Analysis Value in Health. 19: A150. DOI: 10.1016/J.Jval.2016.03.1590  0.397
2015 Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: 1070-8. PMID 26686793 DOI: 10.1016/J.Jval.2015.08.008  0.399
2015 Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal of Health Care For the Poor and Underserved. 26: 1336-58. PMID 26548682 DOI: 10.1353/Hpu.2015.0119  0.497
2015 Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With Chemotherapy. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 26509851 DOI: 10.1097/Igc.0000000000000564  0.445
2015 Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007-2010 after the 2006 introduction of bevacizumab. Lung Cancer (Amsterdam, Netherlands). PMID 26439736 DOI: 10.1016/J.Lungcan.2015.09.017  0.379
2015 Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009. Journal of the American Geriatrics Society. PMID 26200214 DOI: 10.1111/Jgs.13523  0.465
2015 Du XL, Zhang Y. Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal Cancer. Clinical Colorectal Cancer. PMID 26119923 DOI: 10.1016/J.Clcc.2015.05.007  0.372
2015 Poonawalla IB, Lairson DR, Chan W, Piller LB, Du XL. Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: 387-95. PMID 26091592 DOI: 10.1016/J.Jval.2015.01.005  0.416
2015 Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review. Pharmacoeconomics. PMID 26072142 DOI: 10.1007/S40273-015-0304-9  0.431
2015 Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American Journal of Men's Health. PMID 25891393 DOI: 10.1177/1557988315581396  0.365
2015 Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. Bmc Cancer. 15: 190. PMID 25885406 DOI: 10.1186/S12885-015-1180-6  0.325
2015 Wang X, Du XL. Socio-demographic and geographic variations in the utilization of hormone therapy in older women with breast cancer after Medicare Part-D coverage. Medical Oncology (Northwood, London, England). 32: 154. PMID 25837434 DOI: 10.1007/S12032-015-0599-6  0.413
2015 Liu Z, Zhang Y, Franzin L, Cormier JN, Chan W, Xu H, Du XL. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data. International Journal of Oncology. 46: 1819-26. PMID 25672365 DOI: 10.3892/Ijo.2015.2881  0.447
2015 Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. American Journal of Clinical Oncology. 38: 235-41. PMID 23648436 DOI: 10.1097/Coc.0B013E31829378F9  0.338
2015 Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. American Journal of Clinical Oncology. 38: 165-73. PMID 23608830 DOI: 10.1097/Coc.0B013E31828F5B01  0.467
2015 Parikh R, Du X, Morgan R, Lairson D. Treatment patterns among elderly Metastatic Colorectal Cancer patients - a seer-medicare analysis Value in Health. 18: A221. DOI: 10.1016/J.Jval.2015.03.1282  0.419
2014 Du XL, Zhang Y, Hardy D. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women With Breast Cancer From 2000 to 2009. American Journal of Therapeutics. PMID 25756469 DOI: 10.1097/Mjt.0000000000000182  0.472
2014 Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on survival for colorectal cancer: a US database study among elderly. Cancer Epidemiology. 38: 733-40. PMID 25454261 DOI: 10.1016/J.Canep.2014.10.004  0.463
2014 Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. Plos One. 9: e110281. PMID 25333877 DOI: 10.1371/Journal.Pone.0110281  0.389
2014 Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. Bmc Medical Informatics and Decision Making. 14: 88. PMID 25274165 DOI: 10.1186/1472-6947-14-88  0.374
2014 Zhang Y, Fu SS, Du XL. Increasing utilization and predictors of hematopoietic growth factors in patients diagnosed with colorectal cancer: findings from a large national population-based cohort in the USA, 1992-2009. Medical Oncology (Northwood, London, England). 31: 242. PMID 25231751 DOI: 10.1007/S12032-014-0242-Y  0.48
2014 Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study. Plos One. 9: e103735. PMID 25079077 DOI: 10.1371/Journal.Pone.0103735  0.416
2014 Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study. American Journal of Clinical Oncology. PMID 25068470 DOI: 10.1097/Coc.0000000000000104  0.446
2014 Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer. Pharmacoeconomics. 32: 1005-13. PMID 24920195 DOI: 10.1007/S40273-014-0180-8  0.47
2014 Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology. PMID 24755661 DOI: 10.1097/Coc.0000000000000074  0.377
2014 Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer Annals of Oncology. 25: 1234-1242. PMID 24681607 DOI: 10.1093/Annonc/Mdu131  0.471
2014 Tong L, Ahn C, Symanski E, Lai D, Du XL. Temporal trends in the leading causes of death among a large national cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Annals of Epidemiology. 24: 411-7. PMID 24529646 DOI: 10.1016/J.Annepidem.2014.01.005  0.37
2014 Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 34-42. PMID 24438715 DOI: 10.1016/J.Jval.2013.11.007  0.435
2014 Panchal JM, Lairson DR, Chan W, Du XL. Geographic Variation in Oxaliplatin Chemotherapy and Survival in Patients With Colon Cancer. American Journal of Therapeutics. PMID 24368611 DOI: 10.1097/Mjt.0000000000000015  0.475
2014 Poonawalla I, Lairson D, Du X. Cost Assessment of Advanced Ovarian Cancer Treatment in a Large Cohort of Elderly Patients Value in Health. 17: A80. DOI: 10.1016/J.Jval.2014.03.467  0.429
2013 Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes. The American Journal of Managed Care. 19: 805-10. PMID 24304159  0.703
2013 Nurgalieva ZZ, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival. Medical Oncology (Northwood, London, England). 30: 691. PMID 23975632 DOI: 10.1007/S12032-013-0691-8  0.765
2013 Liu P, Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British Journal of Cancer. 109: 1302-9. PMID 23907433 DOI: 10.1038/Bjc.2013.387  0.438
2013 Du XL, Cai Y, Symanski E. Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer. International Journal of Oncology. 42: 2123-33. PMID 23563930 DOI: 10.3892/Ijo.2013.1882  0.469
2013 Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. British Journal of Cancer. 108: 1508-14. PMID 23470470 DOI: 10.1038/Bjc.2013.97  0.637
2013 Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Medical Oncology (Northwood, London, England). 30: 440. PMID 23307252 DOI: 10.1007/S12032-012-0440-4  0.52
2013 Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical Oncology (Northwood, London, England). 30: 419. PMID 23292872 DOI: 10.1007/S12032-012-0419-1  0.76
2013 Panchal JM, Lairson DR, Chan W, Du XL. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer. Clinical Colorectal Cancer. 12: 113-21. PMID 23137529 DOI: 10.1016/J.Clcc.2012.09.007  0.495
2013 Liu L, Wang H, Chen Y, Rustveld L, Liu G, Du XL. Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States. Leukemia & Lymphoma. 54: 1380-6. PMID 23101590 DOI: 10.3109/10428194.2012.743655  0.402
2012 Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 6: 249-57. PMID 22419652 DOI: 10.1177/1557988311432467  0.394
2012 Sail KR, Franzini L, Lairson DR, Du XL. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 72-80. PMID 22264974 DOI: 10.1016/J.Jval.2011.10.004  0.49
2012 Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975-2006. Journal of Women's Health (2002). 21: 393-400. PMID 22149014 DOI: 10.1089/Jwh.2011.2992  0.384
2012 Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian R, Kwak L, Rustveld L, Du XL, Wang M. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 118: 3793-800. PMID 22139816 DOI: 10.1002/Cncr.26627  0.305
2012 Cen P, Banki F, Cheng L, Khalil K, Du XL, Fallon M, Amato RJ, Kaiser LR. Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Annals of Surgical Oncology. 19: 1685-91. PMID 22130619 DOI: 10.1245/S10434-011-2141-1  0.411
2012 Sail K, Franzini L, Lairson D, Du X. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethnicity & Health. 17: 309-23. PMID 22066691 DOI: 10.1080/13557858.2011.628011  0.45
2012 Cen P, Liu C, Du XL. Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer Annals of Oncology. 23: 1503-1511. PMID 22021820 DOI: 10.1093/Annonc/Mdr449  0.452
2012 Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer. Palliative Medicine. 26: 61-71. PMID 21606129 DOI: 10.1177/0269216311407693  0.426
2012 Hu CY, Chan W, Delclos GP, Du XL. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer. American Journal of Clinical Oncology. 35: 228-36. PMID 21383605 DOI: 10.1097/Coc.0B013E318210F812  0.659
2012 Panchal J, Lairson D, Chan W, Du X. PCN138 Geographic Variation and Socio-Demographic Disparity in the Utilization of Oxaliplatin-Containing Chemotherapy in Patients with Stage-III Colon Cancer Value in Health. 15: A233. DOI: 10.1016/J.Jval.2012.03.1255  0.454
2012 Kadakia A, Rajan S, Du X, Johnson M. PCN125 Predictors of Methotrexate Containing Chemotherapy in Women Diagnosed With Early Stage Breast Cancer Value in Health. 15: A230. DOI: 10.1016/J.Jval.2012.03.1242  0.422
2012 Lin LH, Du XL. Sequential chemotherapy and radiotherapy for the treatment of high risk postoperative endometrial cancer Chinese Journal of Cancer Prevention and Treatment. 19: 1109-1111.  0.359
2011 Hu CY, Delclos GL, Chan W, Du XL. Post-treatment surveillance in a large cohort of patients with colon cancer. The American Journal of Managed Care. 17: 329-36. PMID 21718080  0.587
2011 White A, Vernon SW, Franzini L, Du XL. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 811-7. PMID 21546366 DOI: 10.1158/1055-9965.Epi-09-0963  0.562
2011 Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Central European Journal of Public Health. 19: 30-4. PMID 21526653 DOI: 10.21101/Cejph.A3622  0.341
2011 Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer. 117: 1506-15. PMID 21425152 DOI: 10.1002/Cncr.25669  0.351
2011 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 253-62. PMID 21402294 DOI: 10.1016/J.Jval.2010.09.010  0.719
2011 White A, Coker AL, Du XL, Eggleston KS, Williams M. Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas. Cancer. 117: 1080-8. PMID 21351084 DOI: 10.1002/Cncr.25671  0.614
2011 Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, Ursin G, West D, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 560-4. PMID 21266521 DOI: 10.1158/1055-9965.Epi-10-1182  0.357
2011 Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 117: 3242-51. PMID 21264829 DOI: 10.1002/Cncr.25854  0.389
2011 Cheng L, Eng C, Nieman LZ, Kapadia AS, Du XL. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. American Journal of Clinical Oncology. 34: 573-80. PMID 21217399 DOI: 10.1097/Coc.0B013E3181Fe41Ed  0.402
2011 Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Martinez CA, Heslop HE, Brenner MK, Krance RA. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatric Blood & Cancer. 56: 143-51. PMID 21108446 DOI: 10.1016/J.Bbmt.2009.12.403  0.31
2011 Du XL, Xia R, Burau K, Liu CC. Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005. Medical Oncology (Northwood, London, England). 28: S80-90. PMID 20967512 DOI: 10.1007/S12032-010-9717-7  0.45
2011 Hu CY, Delclos GL, Chan W, Du XL. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Medical Oncology (Northwood, London, England). 28: 1062-74. PMID 20714945 DOI: 10.1007/S12032-010-9644-7  0.663
2011 Nurgalieva Z, Liu CC, Du XL. Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer. Medical Oncology (Northwood, London, England). 28: 716-25. PMID 20361359 DOI: 10.1007/S12032-010-9512-5  0.753
2011 Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. American Journal of Therapeutics. 18: 206-15. PMID 20068441 DOI: 10.1097/Mjt.0B013E3181C960Dc  0.488
2010 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy. Journal of the American Geriatrics Society. 58: 1885-95. PMID 20840455 DOI: 10.1111/J.1532-5415.2010.03081.X  0.741
2010 Du XL, Liu CC. Racial/Ethnic disparities in socioeconomic status, diagnosis, treatment and survival among medicare-insured men and women with head and neck cancer. Journal of Health Care For the Poor and Underserved. 21: 913-30. PMID 20693735 DOI: 10.1353/Hpu.0.0331  0.455
2010 Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer. 116: 5279-89. PMID 20665502 DOI: 10.1002/Cncr.25525  0.752
2010 White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer. 116: 4622-31. PMID 20626015 DOI: 10.1002/Cncr.25395  0.66
2010 Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (Baltimore, Md.). 52: 132-41. PMID 20578139 DOI: 10.1002/Hep.23615  0.3
2010 Guadagnolo BA, Liu CC, Cormier JN, Du XL. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort. Cancer. 116: 3505-12. PMID 20564123 DOI: 10.1002/Cncr.25205  0.45
2010 Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Martinez CA, Gottschalk SM, Bollard CM, Heslop HE, Brenner MK, Krance RA. The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1272-81. PMID 20348004 DOI: 10.1016/J.Bbmt.2010.03.016  0.347
2010 Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 1825-33. PMID 20211871 DOI: 10.1093/Annonc/Mdq042  0.405
2010 Du XL, Xia R, Hardy D. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. American Journal of Clinical Oncology. 33: 533-43. PMID 20023570 DOI: 10.1097/Coc.0B013E3181B9Cf1B  0.415
2010 Hardy D, Cormier JN, Xing Y, Liu CC, Xia R, Du XL. Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 90-8. PMID 19884853 DOI: 10.1097/Jto.0B013E3181C0A128  0.41
2010 Nurgalieva Z, Xia R, Liu CC, Burau K, Hardy D, Du XL. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. American Journal of Therapeutics. 17: 148-58. PMID 19417586 DOI: 10.1097/Mjt.0B013E3181A3E50B  0.767
2010 Cen P, Banki F, Cheng L, Kaiser LR, Khalil K, Du XL, Amato RJ. Dynamic changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Journal of Clinical Oncology. 28: 4130-4130. DOI: 10.1200/Jco.2010.28.15_Suppl.4130  0.355
2010 White AL, Vernon SW, Franzini L, Du XL. Abstract B32: Racial/ethnic disparities and trends in screening for colorectal cancer among Medicare beneficiaries with cancer and those without cancer in SEER areas, 1992–2002 Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B32  0.632
2010 Gruschkus SK, Lairson DR, Dunn JK, Risser JMH, Du X. Abstract B129: Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly non‐Hodgkin's lymphoma patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B129  0.759
2010 Sail K, Franzini L, Du X, Lairson D. PCN129 RACIAL DISPARITIES ASSOCIATED WITH TREATMENT AND SURVIVAL IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER Value in Health. 13: A48. DOI: 10.1016/S1098-3015(10)72218-X  0.457
2010 Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN76 COST-EFFECTIVENESS OF WHITE BLOOD CELL GROWTH FACTOR USE AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY Value in Health. 13: A38. DOI: 10.1016/S1098-3015(10)72165-3  0.728
2010 Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS Value in Health. 13: A23. DOI: 10.1016/S1098-3015(10)72092-1  0.715
2009 Nurgalieva Z, Liu CC, Du XL. Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1314-21. PMID 20009883 DOI: 10.1111/Igc.0B013E3181B7662D  0.749
2009 Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Cancer. 115: 5296-308. PMID 19672997 DOI: 10.1002/Cncr.24621  0.396
2009 Badgwell BD, Chang GJ, Rodriguez-Bigas MA, Smith K, Lupo PJ, Frankowski RF, Delclos G, Du XL, Cormier J. Management and outcomes of anorectal infection in the cancer patient. Annals of Surgical Oncology. 16: 2752-8. PMID 19649556 DOI: 10.1245/S10434-009-0626-Y  0.366
2009 Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer. 115: 4807-18. PMID 19626650 DOI: 10.1002/Cncr.24521  0.748
2009 Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer. 115: 2999-3008. PMID 19452539 DOI: 10.1002/Cncr.24363  0.442
2009 Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer. 115: 2388-99. PMID 19399748 DOI: 10.1002/Cncr.24283  0.365
2009 Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau K, Du XL. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer. 115: 2199-211. PMID 19365824 DOI: 10.1002/Cncr.24248  0.648
2009 Holmes L, Chan W, Jiang Z, Ward D, Essien EJ, Du XL. Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. Cancer Control : Journal of the Moffitt Cancer Center. 16: 176-85. PMID 19337204 DOI: 10.1177/107327480901600210  0.608
2009 Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 13-20. PMID 19258935 DOI: 10.1111/Igc.0B013E318197F343  0.425
2009 Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K. Cardiac toxicity associated with anthracyxline-containing chemotherapy in older women with breast cancer (Cancer (2009) 115, (5296-5308)) Cancer. 115: 5849-5851. DOI: 10.1002/Cncr.24744  0.432
2008 Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer. 113: 3231-41. PMID 18937267 DOI: 10.1182/Blood.V112.11.2360.2360  0.474
2008 White A, Liu CC, Xia R, Burau K, Cormier J, Chan W, Du XL. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer. 113: 3400-9. PMID 18932248 DOI: 10.1002/Cncr.23924  0.663
2008 Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, Kwak L, Yi Q, Du XL, Wang M. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 113: 791-8. PMID 18615506 DOI: 10.1002/Cncr.23608  0.315
2008 Du XL, Fang S, Meyer TE. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. American Journal of Clinical Oncology. 31: 125-32. PMID 18391595 DOI: 10.1097/Coc.0B013E3181587890  0.456
2008 Du XL, Fox EE, Lai D. Competing causes of death for women with breast cancer and change over time from 1975 to 2003. American Journal of Clinical Oncology. 31: 105-16. PMID 18391593 DOI: 10.1097/Coc.0B013E318142C865  0.445
2008 Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer. Journal of Surgical Oncology. 97: 583-91. PMID 18381603 DOI: 10.1002/Jso.21028  0.349
2007 Rohatgi N, Du XL, Coker AL, Moye LA, Wang M, Fang S. Chemotherapy and survival for patients with multiple myeloma: findings from a large nationwide and population-based cohort. American Journal of Clinical Oncology. 30: 540-8. PMID 17921717 DOI: 10.1097/Coc.0B013E3180592A30  0.406
2007 Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 18: 660-9. PMID 17892451 DOI: 10.1111/J.1525-1438.2007.01081.X  0.506
2007 Cabanillas ME, Lu H, Fang S, Du XL. Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures. Leukemia & Lymphoma. 48: 1514-21. PMID 17701582 DOI: 10.1080/10428190701471973  0.393
2007 Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 110: 660-9. PMID 17582625 DOI: 10.1002/Cncr.22826  0.519
2007 Holmes L, Chan W, Jiang Z, Du XL. Effectiveness of androgen deprivation therapy in prolonging survival of older men treated for locoregional prostate cancer. Prostate Cancer and Prostatic Diseases. 10: 388-95. PMID 17486111 DOI: 10.1038/sj.pcan.4500973  0.611
2007 Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 109: 2161-70. PMID 17455219 DOI: 10.1002/Cncr.22664  0.464
2007 Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma. American Journal of Clinical Oncology. 30: 163-71. PMID 17414466 DOI: 10.1097/01.Coc.0000251356.63237.4F  0.457
2007 Du XL, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002 Ethnicity and Disease. 17: 122-128. PMID 17274221  0.322
2006 Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Ethnic differences among patients with cutaneous melanoma. Archives of Internal Medicine. 166: 1907-14. PMID 17000949 DOI: 10.1001/Archinte.166.17.1907  0.389
2006 Sanderson M, Coker AL, Perez A, Du XL, Peltz G, Fadden MK. A multilevel analysis of socioeconomic status and prostate cancer risk. Annals of Epidemiology. 16: 901-7. PMID 16843007 DOI: 10.1016/J.Annepidem.2006.02.006  0.35
2006 Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 106: 1276-85. PMID 16475208 DOI: 10.1002/Cncr.21732  0.376
2006 Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Medical Care. 44: 124-31. PMID 16434911 DOI: 10.1097/01.Mlr.0000196978.34283.A6  0.425
2006 Coker AL, Du XL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecologic Oncology. 102: 278-84. PMID 16434087 DOI: 10.1016/J.Ygyno.2005.12.016  0.453
2006 Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. Journal of Clinical Epidemiology. 59: 53-60. PMID 16360561 DOI: 10.1016/J.Jclinepi.2005.06.002  0.406
2005 Cormier JN, Xing Y, Ding M, Ross MI, Lee JE, Mansfield PF, Gershenwald JE, Du XL. Population based assessment of surgical treatment trends for melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7509. PMID 27946148 DOI: 10.1200/Jco.2005.23.16_Suppl.7509  0.317
2005 Du XL, Lairson DR, Begley CE, Fang S. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8620-8. PMID 16314624 DOI: 10.1200/Jco.2005.02.6252  0.447
2005 Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment. 93: 41-7. PMID 16184457 DOI: 10.1007/S10549-005-3702-4  0.478
2005 Du XL, Jones DV, Zhang D. Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 60: 1137-44. PMID 16183952 DOI: 10.1093/Gerona/60.9.1137  0.41
2005 Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6054-62. PMID 16135473 DOI: 10.1200/Jco.2005.21.360  0.311
2005 Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer. 104: 913-24. PMID 15991239 DOI: 10.1002/cncr.21271  0.307
2005 Du XL, Key C, Dickie L, Darling R, Geraci J, Zhang D. 300: External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared to Medical Chart Reviews American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S75C  0.383
2004 Du XL, Key CR, Osborne C. Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. The Breast Journal. 10: 433-9. PMID 15327498 DOI: 10.1111/J.1075-122X.2004.21357.X  0.392
2003 Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Annals of Internal Medicine. 138: 90-7. PMID 12529090 DOI: 10.7326/0003-4819-138-2-200301210-00009  0.33
2002 Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4636-42. PMID 12488407 DOI: 10.1200/Jco.2002.05.088  0.406
2001 Du X, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996 Cancer. 92: 730-737. PMID 11550141 DOI: 10.1002/1097-0142(20010815)92:4<730::AID-CNCR1376>3.0.CO;2-P  0.308
2001 Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from medicare claims data Journal of Clinical Oncology. 19: 1455-1461. PMID 11230491 DOI: 10.1200/Jco.2001.19.5.1455  0.473
2001 Du X, Freeman DH, Syblik DA. What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Research and Treatment. 62: 71-9. PMID 10989987 DOI: 10.1023/A:1006414122201  0.329
2000 Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Medical Care. 38: 719-27. PMID 10901355 DOI: 10.1097/00005650-200007000-00004  0.382
1999 Du X, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995 Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 54. PMID 10536651 DOI: 10.1093/Gerona/54.9.M474  0.39
1999 Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data Journal of Clinical Epidemiology. 52: 463-470. PMID 10360342 DOI: 10.1016/S0895-4356(99)00011-6  0.443
1999 Du X, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer Breast Cancer Research and Treatment. 53: 137-144. PMID 10326790 DOI: 10.1023/A:1006170811237  0.444
Show low-probability matches.